Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
NCT01151709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 838
Last updated 2012-03-07
Summary
This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Massachusetts, Worcester
lead OTHER
Principal Investigators
-
Leslie R Harrold, MD · UMass Medical School
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
Developing A Gout Action Plan in Primary Care Setting in Singapore
NCT07061587 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680 ·Status: TERMINATED ·Phase: PHASE4
-
Improving Gout Care After an ED Visit
NCT06534554 ·Status: RECRUITING ·Phase: NA
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
Arthritis Research UK Gout Treatment Trial - Phase 2
NCT01477346 ·Status: COMPLETED ·Phase: NA
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
A Nurse Led Patient Management Programme to Improve Outcomes in Gout
NCT03345186 ·Status: COMPLETED ·Phase: NA
-
Nurse-Led Telehealth for Gout
NCT06971146 ·Status: RECRUITING ·Phase: NA
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Imagery as Biomarker of Gout
NCT05434858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
The Remote Monitoring of Gout Feasibility Study
NCT06211322 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
NCT04069325 ·Status: UNKNOWN ·Phase: NA
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Virtual Gout Clinic
NCT02790463 ·Status: COMPLETED ·Phase: NA
-
Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout
NCT05925166 ·Status: COMPLETED ·Phase: NA
-
Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout
NCT06653686 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout
NCT05065606 ·Status: UNKNOWN
-
Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
NCT00175019 ·Status: COMPLETED ·Phase: PHASE3
-
Treat-to-target by Email During Urate-lowering Therapy in Gout
NCT04733079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
NCT04875702 ·Status: RECRUITING ·Phase: PHASE4
-
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
NCT04953533 ·Status: UNKNOWN
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3